{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Valeant Pharmaceuticals, which is under scrutiny for its drug-pricing practices, says it is adding three new members to its board, including one from shareholder Pershing Square Capital Management; stock rises.", "type_of_material": "News", "word_count": "434", "lead_paragraph": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "pub_date": "2016-03-10T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Pharmaceuticals Adds Board Members", "print_headline": "Valeant Takes Step to Soothe Investors"}, "snippet": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "multimedia": [{"height": 126, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/03/10/business/valeant-pharmaceuticals-adds-board-members.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Boards of Directors", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}], "blog": [], "_id": "56e0328d38f0d836dc036bd2", "source": "The New York Times"}